2021
DOI: 10.1111/psyp.13934
|View full text |Cite
|
Sign up to set email alerts
|

Are there consistent abnormalities in event‐related EEG oscillations in patients with Alzheimer’s disease compared to other diseases belonging to dementia?

Abstract: Cerebrospinal and structural-molecular neuroimaging in-vivo biomarkers are recommended for diagnostic purposes in Alzheimer's disease (AD) and other dementias; however, they do not explain the effects of AD neuropathology on neurophysiological mechanisms underpinning cognitive processes. Here, an

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 247 publications
1
15
1
Order By: Relevance
“…Measures of oscillatory brain activity are also widely used in clinical and translational research, often with the goal of defining etiological mechanisms, establishing tools for diagnostic assessment, or identifying novel treatment targets. Güntekin et al (2022) provide a review addressing a key question in the neurophysiology of Alzheimer’s disease, namely the extent to which divergent oscillatory dynamics often observed in this condition are a specific marker of the disease. The authors highlight the promise of lower frequency event‐related oscillations as potential neurophysiological biomarkers of Alzheimer’s disease and discuss how studies in other dementias are needed to establish specificity.…”
Section: Overview Of Special Issue Articlesmentioning
confidence: 99%
“…Measures of oscillatory brain activity are also widely used in clinical and translational research, often with the goal of defining etiological mechanisms, establishing tools for diagnostic assessment, or identifying novel treatment targets. Güntekin et al (2022) provide a review addressing a key question in the neurophysiology of Alzheimer’s disease, namely the extent to which divergent oscillatory dynamics often observed in this condition are a specific marker of the disease. The authors highlight the promise of lower frequency event‐related oscillations as potential neurophysiological biomarkers of Alzheimer’s disease and discuss how studies in other dementias are needed to establish specificity.…”
Section: Overview Of Special Issue Articlesmentioning
confidence: 99%
“…Over the past decades, important progress has been made in clinical neuroscience, resulting in improvements to clinical diagnosis and treatment (Walhovd et al 2010;Ewers et al 2011). Backed by increasingly advanced analytical methods, this has enabled fine-grained characterization of neurodegenerative conditions (Gaubert et al 2019;Schumacher et al 2021;Güntekin et al 2021). Yet, from a public-health perspective, rather than focusing on pathology, it is essential to detect risk factors early within the general population in order to provide actionable feedback for preventive medicine, e.g., by targeting life-style changes.…”
Section: Introductionmentioning
confidence: 99%
“…Although changes can be observed in brain activity at rest, specific task-related delays in the implementation, maintenance, or interruption of communications across brain regions could be highly sensitive to age and pathology effects. Recent work (Babiloni et al, 2020 ; Güntekin et al, 2021 ) highlighted the clinical value of investigating oddball-related brain activity to detect pathology effects. Finally, from an epidemiological perspective, future studies should also consider middle-aged individuals (40–60 years) to clarify the association between changes in brain dynamics and later cognitive trajectories.…”
Section: Discussionmentioning
confidence: 99%